Direct answer. A ventral hernia protrudes through the front abdominal wall. Umbilical, epigastric and incisional hernias describe different sites or origins. Selected subtype context. Assessment should identify the type, symptoms and previous surgery before choosing observation or repair. Adult and childhood umbilical care are different. Confidence: moderate in these clinical distinctions; independent comparative device or operation benefit remains unresolved here.
- Ask for the exact abdominal-wall hernia type, site and whether it is recurrent.
- A scar-site hernia is different from a primary belly-button or upper-abdominal hernia.
- Children and adults need different decisions about umbilical hernias.
- New severe pain, vomiting, skin-color change or inability to pass stool/gas needs urgent help.
- Discuss the repair goal, alternatives, implant use and your other health conditions.
- Use the actual team’s recovery instructions; no universal size cutoff or lifting schedule is provided.
Table of contents
- Evidence summary
- Umbilical, epigastric and incisional: what ventral means
- Wall weakness, previous incisions and symptoms that need assessment
- Observation, repair and the purpose of an operation
- Diet, activity and support garments: symptom support versus repair
- Clinical examination, scans and planning a specialist consultation
- Emergency pain, vomiting, obstruction and postoperative warnings
- Consent, prescription review and surgical risks
- Children, pregnancy, ascites and complex abdominal-wall hernias
- Recovery, wound care, daily function and possible recurrence
- Independent evidence, mesh claims and laboratory hypotheses
- Funding and source roles
- Frequently asked questions
- Sources and funding notes
Evidence summary
Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.
| Claim / intervention | Evidence reviewed | Funding / conflicts | Interpretation / limits |
|---|---|---|---|
| Subtype and scar history | Selected public/provider education | Exact experts and source-trial finance unclosed | Confirm type and prior operative record. |
| Adult/child umbilical care | Current national NHS explanation | Website policy is not underlying-trial clearance | Separate pediatric decisions from adult care. |
| Repair planning | Limited adult incisional framework | EHS/BJS support and named device-company relationships | Clinical context, not independent device ranking. |
| Discharge and safety | Current provider/national warnings | Provider income and specific leaflet allocation differ | Use actual instructions and urgent contact routes. |
| Consumer products | No eligible independent structural cure established | Exact human evidence and finance unresolved | No laboratory claim adopted as benefit. |
Umbilical, epigastric and incisional: what ventral means
Umbilical hernias occur around the belly button; epigastric hernias involve the upper front abdomen between the navel and breastbone. Incisional hernias occur at previous abdominal surgical sites. Selected anatomy context. “Ventral” is the broader location term, rather than a synonym for every incisional hernia.
An umbilical hernia involves tissue protruding through a weakness around the navel. In children, it can relate to an opening that did not close fully after the umbilical cord passed through the wall. Selected current context.
Ask whether the report describes a primary hernia, one related to a previous incision, or a recurrence after repair. These distinctions are useful when obtaining a second opinion or understanding why different operations are discussed for people with superficially similar bulges.
Record the site, first appearance, changes during ordinary daily activities and effects on comfort, mobility or clothing. Explain whether there has been previous surgery at that site. Do not use a photograph, a measured bulge or an online symptom checklist to establish a diagnosis or select an operation.
Wall weakness, previous incisions and symptoms that need assessment
An incisional hernia can follow open or minimally invasive abdominal surgery, where fat or intestine protrudes at the weakened surgical site. Selected scar-site context. It can appear after the original recovery rather than immediately after the operation.
Not every symptom near a scar has the same explanation. Ask the clinician what the examination establishes and whether discomfort, a lump or other abdominal symptoms need a separate assessment. Bring the original surgery report so the team can understand the prior procedure.
Describe whether pain limits walking, work, sitting or sleep, and whether the appearance or discomfort has changed. Discuss these effects separately from concerns about the visible shape. The review should establish what treatment would be intended to improve.
A temporarily less visible bulge does not provide a self-clearance rule. Avoid repeatedly testing the area or trying to force an acutely painful lump back into place. A new deterioration should be described to a clinician rather than interpreted only through an old diagnosis.
Observation, repair and the purpose of an operation
Repair may use an open operation or smaller keyhole incisions, with stitches and/or reinforcement chosen for the actual hernia. Selected operative context. Robotic assistance describes an approach, not independently established universal superiority.
For selected adult primary midline incisional hernias, the 2023 EHS guideline discusses imaging when examination is uncertain, shared repair decisions focused on quality of life, and preparation addressing smoking, diabetes and weight. Selected original framework. Its scope does not cover all complex or pediatric hernias.
Ask what benefit is intended: relief of limiting symptoms, management of a particular complication concern or restoration of function. Discuss the alternatives and consequences of deferring the procedure. An observation plan should explain who reviews the condition and where to report changes.
If repair is proposed, ask what the surgeon expects to close or reinforce, why the approach fits the anatomy and what uncertainties remain. This article gives no personal size threshold, mandatory waiting period, weight target, implant choice or fitness-for-surgery rule.
Diet, activity and support garments: symptom support versus repair
No independent supplement, collagen drink, topical product or herbal cure for an abdominal-wall hernia is established in this review. A marketing claim about tissue health does not demonstrate repair of a diagnosed opening or prevention of a complication in a person.
Ask whether a belt, binder or support garment has a role in the agreed clinical plan. Clarify its intended purpose and limitations. Comfort, daily function, structural closure and emergency prevention are different outcomes; a product should not blur them together.
Discuss activity and bowel-management questions with the treating team, particularly if movement or straining is difficult. Request advice that fits work, sport and caregiving demands. No universal lifting limit, exercise ban or laxative schedule is supplied here.
Bring exact supplement labels to the clinician or pharmacist. NCCIH advises discussing nonprescription products and interactions with health professionals. Generic dated safety context. This does not establish a hernia-specific benefit or clear a product around surgery.
Clinical examination, scans and planning a specialist consultation
Suspected hernias need clinical assessment; their type and symptoms help determine the plan. Current national context. Ask whether the diagnosis is confirmed or whether the lump requires further investigation.
The consultation should clarify the actual site, previous operations and symptom history. For an intermittent bulge, explain when it tends to appear during ordinary activity without repeatedly provoking it. Ask what the clinician needs to see or document, and whether a scan would answer a specific uncertainty.
If imaging is requested, ask what question it addresses and whether the result could change the proposed repair or observation plan. A more elaborate test is not automatically more useful. This guide gives no imaging-performance estimate or consumer rule for choosing ultrasound, CT or MRI.
Bring operative reports, relevant imaging, implant records and a medicine list to specialist review. Ask for a plain-language explanation of terms such as “midline,” “recurrent” or “complex.” A clear record allows a second team to examine the actual problem instead of reconstructing it from a general label.
Emergency pain, vomiting, obstruction and postoperative warnings
Severe persistent abdominal pain, vomiting or inability to keep food down, increased swelling with skin-color change, or inability to pass stool or gas needs emergency help. Selected current warning signs. Do not wait for every sign to appear or try home reduction.
Scar-site hernia information also identifies sudden severe pain or color changes around a bulge as emergency concerns. Selected safety context. A previous uncomplicated hernia assessment does not settle a new acute change.
After repair, contact the team for difficult-to-control pain, continuing wound bleeding, pus, redness or swelling, fever or difficulty passing urine. Selected current discharge warnings. Ask how to obtain help outside normal service hours; no safe waiting period is set here.
Tell the receiving service about the hernia, operation date and medicines. Describe the symptom, onset and change plainly. Serious deterioration needs the appropriate urgent service rather than waiting for a support garment, pain remedy or the next routine appointment to answer it.
Consent, prescription review and surgical risks
GSTT lists potential problems including bleeding, infection, urinary retention, injury to nearby organs and recurrence. Selected consent context. Ask how these risks relate to the proposed procedure and your circumstances; general leaflet percentages are not personal probabilities.
Discuss the complete prescription, over-the-counter and supplement list with surgery and anesthesia teams. Request coordinated instructions if anything needs adjustment. This guide gives no anticoagulant interruption, diabetes-drug change, supplement washout, fasting interval or painkiller course.
Explain previous anesthesia reactions, wound infections, abdominal operations and implant problems. Ask what the service needs before consent and who will review any new illness before surgery. Preparation should follow the actual hospital’s procedure-specific instructions rather than a mixture of online leaflets.
If an implant is proposed, ask why it is used, what alternatives are being considered and how its type and location will be recorded. Retain the operation summary and implant information. These records can help a later clinician assess recurrence, pain or another operation without assuming every repair is equivalent.
Children, pregnancy, ascites and complex abdominal-wall hernias
NHS information explains that many childhood umbilical hernias close as the child grows, while adult umbilical hernias usually do not resolve that way. Selected child/adult distinction. Pediatric observation and repair decisions need a child’s clinician; no adult size or recovery rule is extrapolated.
Tell the team about pregnancy or its possibility before imaging, anesthesia and repair decisions. Ask who coordinates surgical and obstetric advice. This guide does not certify an operation, scan, medicine or support garment as suitable during pregnancy.
If you have ascites, liver disease or another important health condition, ask the treating teams to coordinate the hernia discussion. The question is how the actual condition affects planning; a general article cannot declare someone permanently fit or unfit for an operation.
Large, recurrent or technically complex hernias may need a discussion of specialist expertise. Ask which aspects make the case complex and what records the referral requires. Do not apply the limited adult midline guideline’s conclusions to every abdominal-wall reconstruction or a pediatric congenital problem.
Recovery, wound care, daily function and possible recurrence
GSTT explains that discharge instructions identify any further appointments, while pain-control concerns should be discussed with the team. Selected recovery context. This guide gives no fixed lifting, driving, sport, bathing, dressing or return-to-work schedule.
Before surgery, explain practical demands such as manual work, caring responsibilities, stairs and transport. Ask what assistance may be needed and who answers questions after discharge. A workable plan should address the activities you actually do, rather than assuming a standard routine.
Incisional hernias can recur after repair. Selected follow-up context. A new bulge or persistent symptoms deserves reassessment rather than an automatic conclusion that the same operation must be repeated.
At review, bring the operative record and describe wound changes, pain, altered sensation and functional difficulties separately. Ask what explanation is being considered and what further investigation or support is needed. Improvement, discharge and long-term resolution are different questions; arrange the intended follow-up with the responsible team.
Independent evidence, mesh claims and laboratory hypotheses
Confidence is moderate in the type distinctions, need for clinical examination and adult-versus-child care differences. Independent comparative benefit between operations or implants remains unresolved in this review. No numerical recurrence, infection or treatment-success estimate is adopted.
The selected EHS incisional framework has society/journal funding and commercially connected authors. Its original scope and source-study finances must be considered separately from a current society sponsor page. A funding declaration does not automatically clear every trial underlying a guideline.
Ask for evidence relevant to the exact hernia, repair setting and meaningful outcomes: function, pain, complications and recurrence. “Natural,” “biological,” “robotic” and “minimally invasive” are descriptions rather than a complete comparative-evidence verdict. This review does not rank mesh materials or imply that one label determines safety.
Corporate-sponsored or developer-produced efficacy is excluded from the independent verdict. Animal and laboratory tissue studies cannot choose a safe human implant, operation or supplement. Ask who developed and funded an intervention and whether evidence concerns the actual population and procedure being proposed.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 14 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
National website policy, provider accounts and original society-guideline declarations are separate financial records. Current corporate membership does not prove a particular historical transfer. Profiles retain commercially connected authors, reporting dates and unresolved ledgers without inventing page budgets or funding percentages.
| Source | Funding / backers | Country / jurisdiction | Independence | Credibility / incentives / gaps |
|---|---|---|---|---|
| NHS: hernia, 19 May 2026 | National website separate funding policy. Exact expert/page and supporting-study finance unclosed. | United Kingdom; national NHS website, distinct from provider trusts. | Tier 2 public clinical context, provisional. | B, provisional — actual full dated body read. Public review favors accuracy; no underlying-trial clearance. Personal thresholds/recovery schedules excluded. |
| NHS: umbilical hernia, 24 November 2025 | National website separate funding policy. Exact expert/page and supporting-study finance unclosed. | United Kingdom; national NHS website, distinct from provider trusts. | Tier 2 public clinical context, provisional. | B, provisional — actual full dated body read. Public review favors accuracy; no underlying-trial clearance. Personal thresholds/recovery schedules excluded. |
| GSTT: hernia repair overview, January 2026 | Mixed provider receipts; own audited finance separate profile. Exact leaflet/expert and study allocations unclosed. | United Kingdom; Guy’s and St Thomas’ NHS Foundation Trust, London. | Tier 2 provider clinical context, provisional. | C, provisional — actual full body read. Care accountability supports selected discussion; generic reassurance, risk percentages and fixed regimens excluded. |
| GSTT: hernia repair recovery, January 2026 | Mixed provider receipts; own audited finance separate profile. Exact leaflet/expert and study allocations unclosed. | United Kingdom; Guy’s and St Thomas’ NHS Foundation Trust, London. | Tier 2 provider clinical context, provisional. | C, provisional — actual full body read. Care accountability supports selected discussion; generic reassurance, risk percentages and fixed regimens excluded. |
| Cleveland Clinic: ventral hernia, 30 June 2023 | Mixed provider income; accounts, advertising and editorial profiles separate. Exact expert/source-study interests unclosed. | United States; Cleveland Clinic, Cleveland, Ohio. | Tier 2 provider clinical context, provisional. | C, provisional — actual body/date read. Clinical review helps; broad risk/mesh claims and personal cutoffs excluded. |
| Cleveland Clinic: incisional hernia, 24 March 2025 | Mixed provider income; accounts, advertising and editorial profiles separate. Exact expert/source-study interests unclosed. | United States; Cleveland Clinic, Cleveland, Ohio. | Tier 2 provider clinical context, provisional. | C, provisional — actual body/date read. Clinical review helps; broad risk/mesh claims and personal cutoffs excluded. |
| EHS: original midline incisional guideline, 2023 | EHS and BJS grants. Sanders: Medtronic research/lectures/app support; Simons: Intuitive proctor/faculty; Miserez: device-company research/consulting. No industry guideline-development influence reported; full society/source-trial receipts unclosed. | United Kingdom-led, multinational author institutions; British society PDF is a host. | Tier 3 financially connected authors; clinical context. | C, provisional — actual selected scope, diagnosis, shared decisions and declarations read. Methods/declarations aid traceability; restricted scope and residual financial interests remain. |
| NHS: October 2022 content and funding policy | Own policy states DHSC website funding and no advertising or corporate sponsorship; staff outside interests should be declared. Actual payments and current implementation not audited. | United Kingdom; national NHS website; historical policy names NHS Digital, not asserted as the present institutional structure. | Tier 3 institutional editorial/financial self-disclosure. | C, provisional — actual 14 October 2022 policy read; 14 October 2025 review deadline passed. Stated accountability aids provenance, but dated organization names and declaration implementation remain gaps. |
| Guy’s and St Thomas’ own 2025–2026 audited accounts | Own 2025–2026 audited notes3–4: NHS/public commissioner and private-patient income; R&D, education, services and charitable/grant contributions. Directors’ report names Johnson & Johnson Managed Services, Diaverum and Active Care Group partnerships, plus venture/commercial routes. These do not establish payment for a particular leaflet. Full donor, author and page/trial allocations unclosed. | United Kingdom; Guy’s and St Thomas’ NHS Foundation Trust, London, England. | Tier 3 institutional financial/contact self-disclosure. | B provisional for explicitly dated institutional provenance. Statutory/public scrutiny favors accuracy; institutional reporting incentives and allocation gaps remain. Financial context only. |
| NCCIH: using dietary supplements wisely | Federal budget original identifies public support; actual page allocation and every cited product study unclosed. | United States; NIH/NCCIH, Bethesda, Maryland; credited internal 2019 reviewers D. Craig Hopp and David Shurtleff. | Tier 1 public institution, provisional; source-trial finance unclassified. | C, provisional — actual body/date January 2019, with some later references. Federal safety review helps; dated synthesis and unclosed product-study finance do not establish hernia/product benefit. |
| NCCIH: own congressional-budget document | NIH/HHS federal congressional-budget documentation. Requested-year budgets and institutional priorities do not establish the finance of every cited supplement trial. | United States; NCCIH, Bethesda, Maryland. | Tier 1 public institution; budget self-report context. | B, provisional — traceable government-budget process; an older fiscal document and incomplete page/trial donor chain. |
| Cleveland Clinic: original audited 2025/2024 accounts | Provider statutory report; externally audited by EY. Patient/payer revenue, advisory services, research grants, corporate/foundation/individual pledges and investments. | United States; Cleveland Clinic Health System, Cleveland, Ohio. | Tier 3 provider financial self-report with external audit. | B, provisional — issued 9 March 2026, complete 75-page original accessed and relevant notes read. Audit concerns the accounts, not this article or intervention trials. |
| Cleveland Clinic: advertising policy | Site accepts advertising/sponsor revenue; provider retains content/placement approval and states editorial separation. | United States; Cleveland, Ohio. | Tier 3 own commercial-policy disclosure. | B, provisional — policy itself read; January 2020 guidelines state they can change. Actual page advertiser amounts and compliance not independently audited. |
| Cleveland Clinic: editorial policy | Institutional writing and expert-review process; mixed provider funds above, no individual reviewer-payment ledger. | United States; Cleveland, Ohio. | Tier 3 own process disclosure. | B, provisional — actual policy describes professional writers and medical-expert review. Accuracy incentive is credible; an institutional perspective and unverified individual conflicts remain. |
| EHS: current membership and secretariat | Own fee-based membership route. Exact amounts/receipts, donor ledger and guideline allocations unclosed. | Current secretariat c/o CAP Partner, Frederiksberg, Denmark; full legal registration unclosed. | Tier 3 institutional financial self-report. | B, provisional — actual membership/secretariat body read. Direct fee and address information aids traceability; no audit of complete accounts. |
| EHS: current sponsor policy and corporate alliances | Own page solicits company/organization sponsorship and lists corporate-alliance tiers. Named current allocations and any 2023 guideline transfer unclosed. | Society’s stated current secretariat in Denmark; commercial counterparts’ full jurisdictions unclosed. | Tier 3 institutional sponsor self-report. | B, provisional — actual text read. Explicit industry route improves transparency; logo-specific receipts and influence not inferred. |
| EHS: annual-report index | Own index lists 2025/2024 reports. Linked full financial ledgers not read; no receipt or source allocation asserted. | Current secretariat Denmark; institutional reporting route. | Tier 3 institutional reporting index. | C, provisional — actual index read only. Direct route aids follow-up; full ledgers remain an access/review gap. |
Frequently asked questions
Does ventral mean incisional?
Ventral describes the front abdominal-wall location; ask which specific type your report identifies.
Will an adult belly-button hernia disappear like a child’s?
Adult and childhood care differ. Request an individual assessment rather than applying a pediatric observation plan.
Does a bulge size choose the operation?
Ask how symptoms, anatomy, previous surgery and other health conditions affect the plan. No personal cutoff is supplied.
Is one mesh material always safer?
No independent universal ranking is established here; ask about the actual proposed repair and its evidence.
Can I use a binder instead of clinical review?
Ask whether it has any role in the plan and what it cannot establish. New deterioration needs assessment.
When can I return to sport or lifting?
Follow the team’s procedure-specific advice; this guide provides no recovery timetable.
Sources and funding notes
Originals checked 4 October 2026. Actual NHS May2026 general and November2025 umbilical bodies, GSTTJanuary2026 overview/recovery and ClevelandJune2023/March2025 ventral/incisional bodies read. Selected original38-page2023 midline guideline scope, diagnostic/shared-decision, preparation and declaration passages read. Full society financial ledgers remain unreviewed despite current own membership/sponsor/report-index tracing. Provider accounts are actual2025/2024 Cleveland and2025–26 GSTT originals, separate from page allocations. Repeated source material remains bounded; size cutoffs, mesh superiority, universal adult/pediatric algorithms, complication percentages and fixed recovery instructions are excluded.
- NHS: hernia, 19 May 2026 — General assessment and condition names.
- NHS: umbilical hernia, 24 November 2025 — Child/adult distinction and emergency signs.
- GSTT: hernia repair overview, January 2026 — Selected surgical risks; broad no-alternative claim excluded.
- GSTT: hernia repair recovery, January 2026 — Discharge planning and contact signs; no personal activity or dressing schedule.
- Cleveland Clinic: ventral hernia, 30 June 2023 — Abdominal-wall subtype names; no mesh-superiority or urgency-by-size rule.
- Cleveland Clinic: incisional hernia, 24 March 2025 — Surgical-scar origin, recurrence and clinical review; no recovery promise.
- EHS: original midline incisional guideline, 2023 — Selected adult primary midline incisional care; no independent device ranking.
- NHS: October 2022 content and funding policy — October 2022 national website policy; review due passed, providers separate.
- Guy’s and St Thomas’ own 2025–2026 audited accounts — Actual 2025–26 provider accounts; no hernia-leaflet allocation.
- NCCIH: using dietary supplements wisely — January 2019 generic safety; no hernia product benefit.
- NCCIH: own congressional-budget document — Federal request context; no current receipts or efficacy clearance.
- Cleveland Clinic: original audited 2025/2024 accounts — Actual audited 2025/2024 provider accounts; no hernia-page allocation.
- Cleveland Clinic: advertising policy — January 2020 advertising policy; implementation unclosed.
- Cleveland Clinic: editorial policy — Editorial policy; no expert or source-trial clearance.
- EHS: current membership and secretariat — Institutional route/identity only, not trial clearance.
- EHS: current sponsor policy and corporate alliances — Institutional sponsorship route, distinct from original project declarations.
- EHS: annual-report index — Financial provenance route only; not a completed audited-account review.
Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.
